Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.
Young Investigator Awards provide research funding to promising young physicians during the final years of training to support their transition to a faculty appointment and to encourage quality research in clinical oncology. Yu-Wei Chen, MD, MS; R. Dixon Dorand, MD, PhD, and Brian Grieb, MD, PhD, are recipients of Young Investigator Awards.
Merit Awards recognize oncology trainees whose research has scientific importance and is presented in high-quality abstracts at the annual meeting. Chen is also a recipient of a Merit Award. Two other Vanderbilt hematology and oncology fellows receiving this award are Christopher Cann, MD, and Vivek Patel, MD.
“My congratulations go out to all our successful fellows. This is truly a testament to their skills, knowledge and capabilities. All have promising futures, and this is a great first step,” said Jordan Berlin, MD, Ingram Professor of Cancer Research and associate director of Clinical Research at Vanderbilt-Ingram Cancer Center (VICC).
In total, more than $12 million will be awarded at the annual meeting to more 400 recipients representing 32 countries.
“Our hematology and oncology fellows represent the best and brightest across the country, and we’re so fortunate to be able to recruit these talented individuals and train the future leaders of cancer care and research. I think these awards exemplify and validate the Division of Hematology and Oncology’s position as being not only a top tier place for research and patient care, but also for education, mentorship and training,” said Ben Ho Park, MD, PhD, Cornelius Abernathy Craig Professor of Medicine, director of the Division of Hematology and Oncology, and deputy director of VICC.
